Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn.
about
Vein of Galen arteriovenous malformation with PAPVR and use of serial B-type natriuretic peptide levels in the management: a case report and review of the literature.The VICI-trial: high frequency oscillation versus conventional mechanical ventilation in newborns with congenital diaphragmatic hernia: an international multicentre randomized controlled trial.B-type natriuretic peptide: prognostic marker in congenital diaphragmatic herniaEarly elevations in B-type natriuretic peptide levels are associated with poor clinical outcomes in pediatric acute lung injuryPulmonary hypertension in bronchopulmonary dysplasiaN-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort StudyB-type natriuretic Peptide assay for the diagnosis and prognosis of patent ductus arteriosus in preterm infantsPharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates?B-type natriuretic peptide monitoring in the Pediatric ICU population.Brain natriuretic peptide levels in managing pediatric patients with pulmonary arterial hypertensionUpdate on PPHN: mechanisms and treatment.Practical application of natriuretic peptides in paediatric cardiology.Therapeutic targets in neonatal pulmonary hypertension: linking pathophysiology to clinical medicine.N-terminal pro-brain natriuretic peptide level as a screening tool for cardiac involvement in paediatric diseases of extracardiac origin.Cardiac biomarkers in neonatal hypoxic ischaemia.Use of cardiac biomarkers in neonatology.Further findings linking SSRIs during pregnancy and persistent pulmonary hypertension of the newborn: clinical implications.Pathophysiology, management, and outcome of persistent pulmonary hypertension of the newborn: a clinical review.Biomarkers in pediatric heart disease.B-type natriuretic peptide as a parameter for pulmonary hypertension in children. A systematic review.Persistent pulmonary hypertension of the newborn.Diagnosis and treatment of pulmonary hypertension in infancy.The efficacy of cardiac findings in assessing the outcome in preterms with bronchopulmonary dysplasia.B-type natriuretic peptide levels normalise in preterm infants without a patent ductus arteriosus by the fifth postnatal day.Fetal pulmonary vascular remodeling in a rat model induced by hypoxia and indomethacin.BNP, troponin I, and YKL-40 as screening markers in extremely preterm infants at risk for pulmonary hypertension associated with bronchopulmonary dysplasia.The decline and fall of the cardiac biomarker: a good indicator of resolution of cardiac dysfunction following perinatal asphyxia. commentary on D.C. Vijlbrief et al.: Cardiac biomarkers as indicators of hemodynamic adaptation during postasphyxial hCardiac biomarkers as indicators of hemodynamic adaptation during postasphyxial hypothermia treatment.Amino terminal pro B-type natriuretic peptide levels are elevated in the cord blood of neonates with congenital heart defect.Association of BNP, NTproBNP, and early postnatal pulmonary hypertension in very preterm infants.Cardiac troponin T and N-terminal-pro-B type natriuretic peptide reflect myocardial function in preterm infantsN-Terminal-pro-B Type Natriuretic Peptide as a Useful Tool to Evaluate Pulmonary Hypertension and Cardiac Function in CDH Infants
P2860
Q33669247-B1E819C2-7C27-45F4-A83F-58ACD5C1DF51Q34065395-271F1EA2-AE8C-47FC-BE96-77A784D89961Q34516884-35A4968D-41BF-4BDB-ACD5-3078DAC36E2AQ35593180-2CA98966-8074-4828-BABC-3881BAC4AEF4Q35731631-BDB534A9-E3FC-413F-A879-6251D9E84838Q35801673-B7B0F367-E49E-4A40-9C95-CF32CE1CF381Q35866715-6B68B8AC-22EB-46C9-ACE9-6477A251BC57Q36730928-38B57BEF-CC40-4C7A-9023-A4872E19DB1FQ36856379-B3BE3002-04B9-4238-891B-4605F58BD0A0Q36862711-1FC5196F-CED5-40B0-B840-5204B02E3544Q37274564-2E451B5F-7C16-4A87-9ADD-D3902C1DBF18Q37617591-6D07200E-4AF3-42AE-AD6A-235319B9AF16Q37748955-894E0EA4-66FB-4F2F-8160-3EF9E9861B9FQ37754900-FCD8DB98-3930-4740-AB8B-90B0A055D3DBQ37864597-7FE88564-2A61-4029-A527-E27E74280126Q37961207-7B5258D3-6050-4DBD-A436-4D52808F70CAQ38026430-8D498DEE-D56D-4425-9D2B-3CF5E0993A70Q38040821-86BF58EF-9350-4237-A145-AC7B79FBDED1Q38176627-AE92A2D4-4B2D-4844-BD9E-2119C3549491Q38259358-E7F5FD71-7DEF-4EA7-97E1-860869FFAD89Q38571881-21CF309C-D27F-4063-B0D7-A2C78E0727B3Q39940901-6CBD991B-9F27-4E6E-B658-94528929FC6BQ42508912-308A5364-77BC-4E7D-A3A9-D2B5D88F1B82Q44351659-ED85D9C1-AB12-40FC-853B-7F5DF8A87857Q48054868-8F3D9045-2BD2-485B-9054-E70759CC326CQ48203360-39284145-4A12-4601-B1D5-3998B71A6AAFQ48289626-E7130570-C234-4769-81F0-2F9AA418AC54Q48403776-A5AF9689-B7A8-4B00-8E40-6FC7966FE3A0Q48403789-0011F91C-B33A-4BFC-BCAA-718D7DC9077DQ48534455-E9407A1F-B9BE-44FD-862D-E3DA7BD37D0BQ48839302-A9634D22-6229-443D-8B7F-EAF835D01949Q57794316-DD37CDB8-141E-4E2C-8E72-079F8677731DQ57912863-EB33FF94-6A56-4646-AC69-3172D239B9D3
P2860
Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Brain-type natriuretic peptide ...... y hypertension of the newborn.
@en
type
label
Brain-type natriuretic peptide ...... y hypertension of the newborn.
@en
prefLabel
Brain-type natriuretic peptide ...... y hypertension of the newborn.
@en
P2093
P356
P1433
P1476
Brain-type natriuretic peptide ...... y hypertension of the newborn.
@en
P2093
Eric W Reynolds
Henrietta S Bada
Jeff G Ellington
Mark Vranicar
P304
P356
10.1542/PEDS.2004-0525
P407
P577
2004-11-01T00:00:00Z